Main Street Research LLC Gilead Sciences, Inc. Transaction History

Main Street Research LLC

$1.49 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $190,795 - $216,366	2,604 New	2,604 $210,000
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $6,571 - $7,486	-85 Reduced 3.16%	2,604 $216,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $167,578 - $240,584	2,689 New	2,689 $230,000
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $200,924 - $251,780	-3,469 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $98,487 - $111,785	-1,518 Reduced 30.44%	3,469 $252,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $337,570 - $364,200	4,987 New	4,987 $348,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $188,871 - $215,209	-3,334 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $11.8 Million - $14.8 Million	-189,743 Reduced 98.27%	3,334 $211,000
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $670,157 - $778,176	9,264 Added 5.04%	193,077 $14.9 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $11.1 Million - $14.2 Million	176,864 Added 2545.17%	183,813 $13.7 Million
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $369 - $406	6 Added 0.09%	6,949 $452,000
Q3 2019 Oct 21, 2019	BUY	$62.51 - $69.0 $37,881 - $41,814	606 Added 9.56%	6,943 $440,000
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $9,899 - $11,100	-160 Reduced 2.46%	6,337 $428,000
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $56,589 - $63,395	-905 Reduced 12.23%	6,497 $422,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $54,788 - $71,495	905 Added 13.93%	7,402 $463,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $16,465 - $18,230	-231 Reduced 3.43%	6,497 $502,000
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $64,879 - $75,680	-1,000 Reduced 12.94%	6,728 $477,000
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $26,295 - $32,056	361 Added 4.9%	7,728 $583,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $67,592 - $79,344	950 Added 14.8%	7,367 $528,000
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $462,729 - $548,460	6,417	6,417 $520,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Research LLC with notifications on news.

Account